NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs021190020

Registered date:18/02/2020

Effect of lactoferrin for vaginitis and cervicitis in obstetrics

Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiedVacterial vaginitis, threatened preterm birth
Date of first enrollment18/02/2020
Target sample size40
Countries of recruitment
Study typeInterventional
Intervention(s)Give enteric lactoferrin to pregnant women with abnormal vaginal flora

Outcome(s)

Primary Outcome1. Intractable vagus or cervical inflammation patients improve vaginal discharge findings by taking lactoferrin-enter-soluble tablets 2. Preterm Birth Rate of Pregnant Women With Lactoferrin Enter-Dissolved Tablets
Secondary OutcomeEvaluation of side effects and other safety caused by lactoferrin-enter-lytic tablets

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximum< 50age old
GenderFemale
Include criteria1) Maternal age: 20 years old or older, under 50 years 2) Pregnant women who plan to deliver in our department 3) Patients who have been diagnosed with intractable vaginitis or cervicitis, and who have not improved their vaginal discharge findings with conventional treatment
Exclude criteriaIf not gain consent

Related Information

Contact

Public contact
Name Hiroshi Miura
Address 44-2, Hasunuma, Hiro-omote, akita, akita Akita Japan 010-8543
Telephone +81-18-884-6163
E-mail miurah@doc.med.akita-u.ac.jp
Affiliation Akita University Hospital
Scientific contact
Name Hiroshi Miura
Address 44-2, Hasunuma, Hiro-omote, akita, akita Akita Japan 010-8543
Telephone +81-18-884-6163
E-mail miurah@doc.med.akita-u.ac.jp
Affiliation Akita University Hospital